{"id":70270,"date":"2022-12-22T23:12:09","date_gmt":"2022-12-22T23:12:09","guid":{"rendered":"https:\/\/www.imperialcrs.com\/blog\/?p=70270"},"modified":"2023-12-06T01:14:04","modified_gmt":"2023-12-06T01:14:04","slug":"clinical-trial-enrollment-strategies","status":"publish","type":"post","link":"https:\/\/www.imperialcrs.com\/blog\/patient-engagement\/clinical-trial-enrollment-strategies\/","title":{"rendered":"Clinical Trial Enrollment Timelines: Hidden Causes Behind Big Delays"},"content":{"rendered":"

This is the second in my three-part series revealing hidden causes behind delays in clinical studies. The first part is <\/em>here<\/em><\/a>. This installment explores strategies to meet clinical trial enrollment<\/em> goals.<\/em><\/p>\n

Tell me when your first patient was enrolled, and I will tell you the chances your study will be a success. It\u2019s not a magic trick, it\u2019s just statistics.<\/p>\n

First Patient In (FPI) is a key indicator of the overall success of a study. If that first patient is enrolled on time or within 30 days of the FPI goal, your study will begin on sound footing. The further you miss that goal, the more success will elude you. Here are the statistics:<\/p>\n

\"clinical<\/p>\n

Getting that first patient into the study on time is critical. If that goal isn\u2019t met, it takes longer to gain traction and raises the likelihood that you will not hit your clinical trial enrollment targets. Your study will not meet its timelines.<\/p>\n

This makes strategic patient recruitment an important tool in meeting FPI and LPFV (Last Patient\/First Visit) goals.<\/p>\n

In the past, about 70 percent of our business consisted of rescue programs for low-enrolling studies. We have seen considerable progress in this area: more than 70 percent of the studies we support today have<\/u> proactive recruitment programs.<\/p>\n

Sponsors have grown more sophisticated with recruitment, and many have even created internal departments tasked with accelerating enrollment. Merck\u2019s<\/a> Global Trial Optimization team is a noteworthy example.<\/p>\n

Nevertheless, there is still room for improvement. A survey conducted by Imperial<\/a> a few years ago revealed that 45 percent of line managers at sponsor companies had no proactive recruitment plans but also lacked the authority to put plans in place. Unfortunately, they are setting themselves up for delays.<\/p>\n

Bring in the sites as a clinical trial enrollment strategy<\/strong><\/h2>\n

Sites are the front lines of research and enrollment. Maximizing communication with sites early and often will help boost their performance.<\/p>\n

Sites have tremendous insights and expertise that can be tapped. Here are tips on maximizing site performance:<\/p>\n